Rakez Kayed

Active 1999–2025

126
Papers
34,544
Citations
75
h-index
119
i10-index

Citations

Citations per year for Rakez Kayed1977: 2 citations1978: 1 citations1999: 2 citations2000: 7 citations2001: 12 citations2002: 12 citations2003: 40 citations2004: 181 citations2005: 189 citations2006: 376 citations2007: 487 citations2008: 533 citations2009: 558 citations2010: 610 citations2011: 612 citations2012: 603 citations2013: 499 citations2014: 583 citations2015: 558 citations2016: 497 citations2017: 485 citations2018: 452 citations2019: 1,133 citations2020: 1,477 citations2021: 1,382 citations2022: 1,220 citations2023: 1,005 citations2024: 1,417 citations2025: 769 citations2026: 15 citations1979–1998: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,889 citing papers, 29.2% of this breakdownChina: 1,596 citing papers, 9.5% of this breakdownUnited Kingdom: 1,076 citing papers, 6.4% of this breakdownGermany: 896 citing papers, 5.4% of this breakdownItaly: 775 citing papers, 4.6% of this breakdownIndia: 593 citing papers, 3.5% of this breakdownCanada: 559 citing papers, 3.3% of this breakdownJapan: 467 citing papers, 2.8% of this breakdownAustralia: 462 citing papers, 2.8% of this breakdownSpain: 452 citing papers, 2.7% of this breakdownFrance: 442 citing papers, 2.6% of this breakdownSweden: 364 citing papers, 2.2% of this breakdown
0%29.2%Other 25%

Fields

  • Medicine59.4%
  • Biochemistry, Genetics and Molecular Biology21.9%
  • Neuroscience12.8%
  • Immunology and Microbiology1%
  • Materials Science1%
  • Computer Science0.7%
  • Other3.2%

Topics

  • Alzheimer's disease research and treatments20.4%
  • Neuroinflammation and Neurodegeneration Mechanisms5.8%
  • Cholinesterase and Neurodegenerative Diseases4.4%
  • Computational Drug Discovery Methods3.6%
  • Neuroscience and Neuropharmacology Research3.2%
  • Prion Diseases and Protein Misfolding2.6%
  • Other60%

Coauthors

All papers

Open in search
  1. NLRP3 inflammasome activation drives tau pathology

    Authors: , , , , , , , , , , , , , , , , , , , , , - Nature 2019 cited by 1,559

  2. Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles

    Authors: , , , , , , , , , - Neuron 2003 cited by 4,130

  3. iPSC-Derived Human Microglia-like Cells to Study Neurological Diseases

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Neuron 2017 cited by 1,174

  4. Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer’s Disease, Parkinson’s Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Guanghong Wei, Fabio Sterpone, Andrew J. Doig, Philippe Derreumaux - Chemical Reviews 2021 cited by 668

  5. Amyloid β, Tau, and α-Synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseases

    Authors: , - Progress in Neurobiology 2022 cited by 273

  6. Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo

    Authors: , , , , , , , , , , - Journal of Biological Chemistry 2004 cited by 2,306

  7. The Role of Amyloid-β Oligomers in Toxicity, Propagation, and Immunotherapy

    Authors: , , - EBioMedicine 2016 cited by 744

  8. Tau oligomer induced HMGB1 release contributes to cellular senescence and neuropathology linked to Alzheimer’s disease and frontotemporal dementia

    Authors: , , , , , , , , , - Cell Reports 2021 cited by 217

  9. Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis

    Authors: , , , , , , - Science 2003 cited by 4,088

  10. Alzheimer’s disease brain-derived extracellular vesicles spread tau pathology in interneurons

    Authors: , , , , , , , , , , , , , , , , - Brain 2020 cited by 276

  11. Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice

    Authors: , , , , , - Molecular Neurodegeneration 2011 cited by 618

  12. Identification of oligomers at early stages of tau aggregation in Alzheimer's disease

    Authors: , , , , , , - The FASEB Journal 2012 cited by 525

  13. Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau

    Authors: , , , , , , , - Scientific Reports 2012 cited by 507

  14. Senescence, brain inflammation, and oligomeric tau drive cognitive decline in Alzheimer's disease: Evidence from clinical and preclinical studies

    Authors: , , , - Alzheimer s & Dementia 2023 cited by 101

  15. Small Misfolded Tau Species Are Internalized via Bulk Endocytosis and Anterogradely and Retrogradely Transported in Neurons

    Authors: , , , , , , , , , , , - Journal of Biological Chemistry 2012 cited by 547

  16. Soluble pathogenic tau enters brain vascular endothelial cells and drives cellular senescence and brain microvascular dysfunction in a mouse model of tauopathy

    Authors: , , , , , , , , , , , , , , , - Nature Communications 2023 cited by 71

  17. Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers

    Authors: , , , , , , , , , , , , , - Molecular Neurodegeneration 2007 cited by 782

  18. Accelerated neurodegeneration through chaperone-mediated oligomerization of tau

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2013 cited by 321

  19. RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory

    Authors: , , , , , , , - Nature 2006 cited by 2,758

  20. Aβ Amyloid Pathology Affects the Hearts of Patients With Alzheimer’s Disease

    Authors: , , , , , , , , - Journal of the American College of Cardiology 2016 cited by 201

  21. Soluble tau aggregates, not large fibrils, are the toxic species that display seeding and cross‐seeding behavior

    Authors: , , , , , , - Protein Science 2018 cited by 157

  22. Lysine 63-linked ubiquitination of tau oligomers contributes to the pathogenesis of Alzheimer’s disease

    Authors: , , , , , , , , , , , - Journal of Biological Chemistry 2022 cited by 63

  23. Revisiting the intersection of amyloid, pathologically modified tau and iron in Alzheimer’s disease from a ferroptosis perspective

    Authors: , , , , , , - Progress in Neurobiology 2019 cited by 143

  24. Cerebral Microvascular Accumulation of Tau Oligomers in Alzheimer’s Disease and Related Tauopathies

    Authors: , , , , , , , , , , , , , - Aging and Disease 2017 cited by 122